, APAC
105 views
/Allianz

Allianz APAC posts 15% YoY jump in business volume for FY 2024

Taiwan recorded the largest NBV expansion with a 68% increase.

Allianz Asia-Pacific (APAC) posted a 15% year-on-year (YoY) jump in total business volume (TBV) for fiscal year 2024 (FY 2024), reaching $9.328b (€8.8b), driven by both Life & Health $7.208b (€6.8b, +16%) and Property & Casualty $2.12b (€2.0b, +11%). 

Operating profit rose 6% to $842.7m (€795m), despite a less favorable health claims environment. The Life & Health segment remained a key driver of growth, with new business value (NBV) surging 31% to $749.42m (€707m).

Taiwan led NBV expansion with a 68% increase, followed by China (+31%) and Thailand (+24%). Annualised new premiums (ANP) climbed 12% to $1.2402b (€1.17b), with significant contributions from Taiwan (+27%), Malaysia (+15%), and Thailand (+13%). 

Despite challenges such as lower interest rates in China, rising medical inflation, and climate-related risks, Allianz APAC continued to expand its distribution capabilities and product offerings.

Regional CEO Anusha Thavarajah attributed the strong performance to Allianz’s strategic focus on transformation and customer engagement under its Pinnacle 2030 initiative.

($1.00 = €0.94)
 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.